178 related articles for article (PubMed ID: 30686748)
1. Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis.
Delanaye P; Bataille S; Quinonez K; Buckinx F; Warling X; Krzesinski JM; Pottel H; Burtey S; Bruyère O; Cavalier E
J Ren Nutr; 2019 Nov; 29(6):511-520. PubMed ID: 30686748
[TBL] [Abstract][Full Text] [Related]
2. Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity.
Orioli L; Samaras S; Sawadogo K; de Barsy M; Lause P; Deswysen Y; Navez B; Thissen JP; Loumaye A
Clin Nutr; 2024 Jul; 43(7):1800-1808. PubMed ID: 38861892
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women.
Hofmann M; Halper B; Oesen S; Franzke B; Stuparits P; Tschan H; Bachl N; Strasser EM; Quittan M; Ploder M; Wagner KH; Wessner B
Exp Gerontol; 2015 Apr; 64():35-45. PubMed ID: 25681638
[TBL] [Abstract][Full Text] [Related]
4. Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults.
Chew J; Tay L; Lim JP; Leung BP; Yeo A; Yew S; Ding YY; Lim WS
J Nutr Health Aging; 2019; 23(10):979-986. PubMed ID: 31781728
[TBL] [Abstract][Full Text] [Related]
5. Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men.
Fife E; Kostka J; Kroc Ł; Guligowska A; Pigłowska M; Sołtysik B; Kaufman-Szymczyk A; Fabianowska-Majewska K; Kostka T
BMC Geriatr; 2018 Aug; 18(1):200. PubMed ID: 30165829
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients.
Wang H; Casaburi R; Taylor WE; Aboellail H; Storer TW; Kopple JD
Kidney Int; 2005 Jul; 68(1):352-61. PubMed ID: 15954927
[TBL] [Abstract][Full Text] [Related]
7. Significance of serum Myostatin in hemodialysis patients.
Esposito P; Battaglia Y; La Porta E; Grignano MA; Caramella E; Avella A; Peressini S; Sessa N; Albertini R; Di Natali G; Lisi C; Gregorini M; Rampino T
BMC Nephrol; 2019 Dec; 20(1):462. PubMed ID: 31829144
[TBL] [Abstract][Full Text] [Related]
8. Muscle insulin-like growth factor status, body composition, and functional capacity in hemodialysis patients.
Macdonald JH; Phanish MK; Marcora SM; Jibani M; Bloodworth LL; Holly JM; Lemmey AB
J Ren Nutr; 2004 Oct; 14(4):248-52. PubMed ID: 15483786
[TBL] [Abstract][Full Text] [Related]
9. Low-Plasma Insulin-Like Growth Factor-1 Associates With Increased Mortality in Chronic Kidney Disease Patients With Reduced Muscle Strength.
Chen Z; Nilsson E; Lindholm B; Heimbürger O; Barany P; Stenvinkel P; Qureshi AR; Chen J
J Ren Nutr; 2023 Mar; 33(2):298-306. PubMed ID: 35792256
[TBL] [Abstract][Full Text] [Related]
10. Association of Uremic Toxins and Inflammatory Markers with Physical Performance in Dialysis Patients.
Pajek M; Jerman A; Osredkar J; Ponikvar JB; Pajek J
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30275410
[TBL] [Abstract][Full Text] [Related]
11. Serum reference value of two potential doping candidates-myostatin and insulin-like growth factor-I in the healthy young male.
Han DS; Huang CH; Chen SY; Yang WS
J Int Soc Sports Nutr; 2017; 14():2. PubMed ID: 28077934
[TBL] [Abstract][Full Text] [Related]
12. Geriatric nutritional risk index, muscle function, quality of life and clinical outcome in hemodialysis patients.
Beberashvili I; Azar A; Sinuani I; Shapiro G; Feldman L; Sandbank J; Stav K; Efrati S
Clin Nutr; 2016 Dec; 35(6):1522-1529. PubMed ID: 27117682
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis.
Kittiskulnam P; Chertow GM; Carrero JJ; Delgado C; Kaysen GA; Johansen KL
Kidney Int; 2017 Jul; 92(1):238-247. PubMed ID: 28318630
[TBL] [Abstract][Full Text] [Related]
14. Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis.
Han DS; Chen YM; Lin SY; Chang HH; Huang TM; Chi YC; Yang WS
Clin Endocrinol (Oxf); 2011 Dec; 75(6):857-63. PubMed ID: 21605155
[TBL] [Abstract][Full Text] [Related]
15. Myokines in Acromegaly: An Altered Irisin Profile.
Mizera Ł; Halupczok-Żyła J; Kolačkov K; Zembska A; Grzegrzółka J; Jędrzejuk D; Bolanowski M; Daroszewski J
Front Endocrinol (Lausanne); 2021; 12():728734. PubMed ID: 34795636
[TBL] [Abstract][Full Text] [Related]
16. Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure.
Furihata T; Kinugawa S; Fukushima A; Takada S; Homma T; Masaki Y; Abe T; Yokota T; Oba K; Okita K; Tsutsui H
Int J Cardiol; 2016 Oct; 220():483-7. PubMed ID: 27390974
[TBL] [Abstract][Full Text] [Related]
17. Measurement of Muscle Strength in Haemodialysis Patients by Pinch and Hand Grip Strength and Comparison to Lean Body Mass Measured by Multifrequency Bio-Electrical Impedance.
Omichi Y; Srivareerat M; Panorchan K; Greenhall GH; Gupta S; Davenport A
Ann Nutr Metab; 2016; 68(4):268-75. PubMed ID: 27288418
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients.
Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
BMC Nephrol; 2019 Feb; 20(1):54. PubMed ID: 30764799
[TBL] [Abstract][Full Text] [Related]
19. Effect of exercise on mRNA levels for growth factors in skeletal muscle of hemodialysis patients.
Kopple JD; Cohen AH; Wang H; Qing D; Tang Z; Fournier M; Lewis M; Casaburi R; Storer T
J Ren Nutr; 2006 Oct; 16(4):312-24. PubMed ID: 17046615
[TBL] [Abstract][Full Text] [Related]
20. The Associations Between Body Cell Mass and Nutritional and Inflammatory Markers in Patients With Chronic Kidney Disease and in Subjects Without Kidney Disease.
Rymarz A; Bartoszewicz Z; Szamotulska K; Niemczyk S
J Ren Nutr; 2016 Mar; 26(2):87-92. PubMed ID: 26559600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
